Brady Kelly has filed 5 insider transactions across 1 company since March 2026.
Most recent transaction: a option exercise of 180 shares of Seres Therapeutics, Inc. ($MCRB) on May 15, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Seres Therapeutics, Inc. | $MCRB | Brady Kelly | See Remarks | M | Common Stock | 180 | $0.00 | 8,621.0000 | 9,046,519 | 2.13% | 0.00% |
| May 18, 2026 | Seres Therapeutics, Inc. | $MCRB | Brady Kelly | See Remarks | S | Common Stock | 59 | $7.53 | 8,562.0000 | 9,046,519 | 0.68% | 0.00% |
| May 15, 2026 | Seres Therapeutics, Inc. | $MCRB | Brady Kelly | See Remarks | M | Restricted Stock Units | 89 | $0.00 | 269.0000 | 9,046,519 | 24.86% | 0.00% |
| May 15, 2026 | Seres Therapeutics, Inc. | $MCRB | Brady Kelly | See Remarks | M | Restricted Stock Units | 91 | $0.00 | 639.0000 | 9,046,519 | 12.47% | 0.00% |
| March 4, 2026 | Seres Therapeutics, Inc. | $MCRB | Brady Kelly | See Remarks | A | Stock Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 9,046,519 | 9999.99% | 0.62% |